GH Research GHRS
NASDAQ GHRS
$27.92 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:06 PM EDT

GH Research (GHRS) Enterprise Value (2021 - 2026)

GH Research (GHRS) posted quarterly Enterprise Value of -$246.3 million for Q4 2025, down 104.91% year-over-year from $5.0 billion in Q4 2024, and up 1.36% quarter-over-quarter from -$249.7 million in Q3 2025.

Analysis

GH Research (GHRS) Enterprise Value (2021 - 2026) Analysis & Trends

GH Research's Enterprise Value history runs 6 years deep, the most recent figure standing at -$246.3 million for Q4 2025.

  • In Q4 2025, Enterprise Value fell 104.91% year-over-year to -$246.3 million; the TTM figure through Dec 2025 stood at -$246.3 million (down 104.91% YoY), while the FY2025 annual figure was -$246.3 million, down 104.91% from the prior year.
  • Enterprise Value for Q4 2025 stood at -$246.3 million, up from -$249.7 million in the prior quarter.
  • The five-year high for Enterprise Value was -$120.2 million in Q4 2024, with the low at -$280.7 million in Q3 2021.
  • The 5-year median for Enterprise Value is -$206.1 million (2022), against an average of -$200.6 million.
  • The sharpest annual moves came in 2021 and 2023: Enterprise Value sank 5535620.0% in 2021, then surged 44.76% in 2023.
  • GH Research's Enterprise Value stood at -$276.8 million in 2021, then jumped by 40.04% to -$166.0 million in 2022, then increased by 19.23% to -$134.0 million in 2023, then increased by 10.34% to -$120.2 million in 2024, then tumbled by 104.91% to -$246.3 million in 2025.
  • Business Quant data shows GHRS's Enterprise Value at -$246.3 million in Q4 2025, -$249.7 million in Q3 2025, and -$253.9 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 GH Research 1.70 Bn 1.34 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.30 Bn
Mar 31, 2026 604.81 Mn
Dec 31, 2025 507.07 Mn
Sep 30, 2025 494.35 Mn
Jun 30, 2025 380.35 Mn
Mar 31, 2025 316.36 Mn
Dec 31, 2024 244.02 Mn
Sep 30, 2024 225.49 Mn
Jun 30, 2024 477.55 Mn
Mar 31, 2024 425.79 Mn
Dec 31, 2023 277.34 Mn
Sep 30, 2023 380.88 Mn
Jun 30, 2023 465.60 Mn
Mar 31, 2023 256.51 Mn
Dec 31, 2022 339.69 Mn
Sep 30, 2022 347.54 Mn
Jun 30, 2022 253.79 Mn
Mar 31, 2022 680.71 Mn
Dec 31, 2021 936.87 Mn
Sep 30, 2021 344.86 Mn